 | Up a level |
Journal Article
Baertsch, Marc-Andrea, Schlenzka, Jana, Lisenko, Katharina, Krzykalla, Julia, Becker, Natalia, Weisel, Katja, Noppeney, Richard, Martin, Hans, Lindemann, Hans W., Haenel, Mathias, Nogai, Axel, Scheid, Christof, Salwender, Hans 
ORCID: 0000-0001-7803-0814, Fenk, Roland, Graeven, Ullrich, Reimer, Peter, Schmidt-Hieber, Martin, Goerner, Martin, Schmidt-Wolf, Ingo G. H., Klein, Stefan, Ho, Anthony D., Goldschmidt, Hartmut and Wuchter, Patrick
(2017).
Cyclophosphamide-based stem cell mobilization in relapsed multiple myeloma patients: A subgroup analysis from the phase III trial ReLApsE.
Eur. J. Haematol., 99 (1).
S. 42 - 51.
HOBOKEN:
WILEY.
ISSN 1600-0609
Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Braun, Andrejs ORCID: 0000-0003-0925-5598, Taylor-Weiner, Amaro, Jebaraj, Billy Michael Chelliah, Robrecht, Sandra, Krzykalla, Julia, Pan, Heng, Giza, Adam, Akylzhanova, Gulnara, Holzmann, Karlheinz, Scheffold, Annika, Johnston, Harvey E., Yeh, Ru-Fang, Klymenko, Tetyana, Tausch, Eugen, Eichhorst, Barbara, Bullinger, Lars ORCID: 0000-0002-5890-5510, Fischer, Kirsten, Weisser, Martin, Robak, Tadeusz ORCID: 0000-0002-3411-6357, Schneider, Christof, Gribben, John, Dahal, Lekh N., Carter, Mathew J., Elemento, Olivier, Landau, Dan A., Neuberg, Donna S., Cragg, Mark S., Benner, Axel, Hallek, Michael, Wu, Catherine J., Doehner, Hartmut, Stilgenbauer, Stephan and Mertens, Daniel
(2021).
Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia.
Nat. Commun., 12 (1).
BERLIN:
NATURE PORTFOLIO.
ISSN 2041-1723
Bloehdorn, Johannes ORCID: 0000-0003-1433-9702, Krzykalla, Julia, Holzmann, Karlheinz, Gerhardinger, Andreas, Jebaraj, Billy Michael Chelliah, Bahlo, Jasmin, Humphrey, Kathryn, Tausch, Eugen, Robrecht, Sandra, Mertens, Daniel ORCID: 0000-0003-0227-7188, Schneider, Christof, Fischer, Kirsten, Hallek, Michael ORCID: 0000-0002-7425-4455, Doehner, Hartmut, Benner, Axel and Stilgenbauer, Stephan
(2022).
Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.
Haematologica, 107 (3).
S. 615 - 625.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078
Bloehdorn, Johannes, Krzykalla, Julia, Jebaraj, Billy Michael Chelliah, Holzmann, Karlheinz, Bahlo, Jasmin, Robrecht, Sandra, Humphrey, Kathryn, Wenger, Michael, Tausch, Eugen, Schneider, Christof, Bullinger, Lars, Fischer, Kirsten, Hallek, Michael, Mertens, Daniel, Benner, Axel, Doehner, Hartmut and Stilgenbauer, Stephan (2018). MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy. Blood, 132. WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020